ExxPharma Therapeutics and Halo Pharmaceutical have entered into a collaboration agreement to develop and manufacture Phase I - III clinical test materials using ExxPharma’s proprietary technologies and Halo’s GMP manufacturing capabilities.


In addition, ExxPharma has signed development agreements with two drug discovery companies to develop oral dosage forms that require solubility enhancement of the active ingredients using ExxPharma’s technologies. The products are currently at different stages of development.